Axogen, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Axogen, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $4.23M, a 77.34% increase year-over-year.
- Axogen, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $2.40M, a 317.60% increase year-over-year.
- Axogen, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $2.38M.
- Axogen, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $574.00K.
- Axogen, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $4.00M, a 3.04% increase from fiscal 2018.
- Axogen, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $3.88M, a 170.85% increase from fiscal 2017.
- Axogen, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $1.43M, a 33.02% increase from fiscal 2016.
- Axogen, Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $1.08M, a 110.22% increase from fiscal 2015.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $4.23M 10-Q · filed 2026-04-28 | |
| 2025-09-30 | $2.40M 10-Q · filed 2025-10-29 | |
| 2025-03-31 | $2.38M 10-Q · filed 2026-04-28 | |
| 2024-09-30 | $574.00K 10-Q · filed 2025-10-29 | |
| 2020-03-31 | $316.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $4.00M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $625.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.56M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $950.00K 10-Q · filed 2020-05-06 | |
| 2018-12-31 | $3.88M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $867.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $1.49M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $419.00K 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $1.43M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $1.08M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $512.80K 10-K · filed 2018-02-28 | |
| 2014-12-31 | $135.84K 10-K · filed 2016-02-29 | |
| 2013-12-31 | $73.33K 10-K · filed 2015-03-05 | |
| 2012-12-31 | $15.65K 10-K · filed 2014-03-06 | |
| 2011-12-31 | $26.48K 10-K/A · filed 2013-08-07 | |
| 2010-12-31 | $3.92K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |